Nathalie Compagnone

Nathalie Compagnone

CEO, ICDD

Location
Marseille Area, France
Industry
Pharmaceuticals

As a LinkedIn member, you'll join 300 million other professionals who are sharing connections, ideas, and opportunities.

  • See who you and Nathalie Compagnone know in common
  • Get introduced to Nathalie Compagnone
  • Contact Nathalie Compagnone directly

View Nathalie's full profile

Nathalie Compagnone's Overview

Current
  • Founder and CEO at ICDD-sas
  • Member at Eurobiomed & Euromediag
Past
Education
  • Université de Besançon - Franche-comté
  • Université de Besançon - Franche-comté
  • Ecole Supérieure d'Agriculture d'Angers
Connections

429 connections

Websites

Nathalie Compagnone's Summary

My professional experience has led me to better understand the drug development process.
Having been in charge of advancing drugs toward the clinic, has made me realize the lack of pertinent decision tools allowing the rational selection or de-selection of products.
This realization has spurred the creation of ICDD a company dedicated to developing DECISION TOOLS (services and technologies) contributing to reduction of drug attrition and selection of safer, better-tolerated drugs.

Specialties

Pre-clinical safety, Neurosciences, Mitochondrial behavior

Nathalie Compagnone's Experience

Founder and CEO

ICDD-sas

Partnership; 1-10 employees; Biotechnology industry

2007Present (7 years)

• ICDD-sas is a biotech company developing pharmaco-toxicology & clinical biomarkers to reduce the cost and risk associated with drug development.

• ICDD-sas helps you fail unsafe leads sooner and improve your probability of success in developing safest candidates through clinical trials.

Member

Eurobiomed & Euromediag

2007Present (7 years)

Member of Eurobiomed Scientific Committee

Program manager

Trophos-sa

Privately Held; 11-50 employees; Biotechnology industry

20042006 (2 years)

Head of pre-clinical development, up to the lead selection in the Huntington Disease program

Educational Institution; 10,001+ employees; Research industry

19972004 (7 years)

• Role & mechanism of action of neurostreoids in the developing central nervous system.
• Establishment of the therapeutic properties of DHEA in the regeneration of the adult spinal cord after traumatic injury
• Analysis of the bladder recovery after spinal cord injury

post-doc

INSERM U33

Government Agency; 10,001+ employees; Research industry

19961997 (1 year)

Steroid biochemistry

Educational Institution; 10,001+ employees; Research industry

19931996 (3 years)

Neurosteroids

Nathalie Compagnone's Skills & Expertise

  1. Drug development
  2. Toxicity profiling
  3. CNS diseases
  4. Neurodegeneration
  5. Cancer
  6. Diabetes
  7. Pre-clinical development rationalization
  8. Systems Biology
  9. Neuroscience
  10. Drug Development
  11. Clinical Development
  12. Drug Discovery
  13. Biotechnology
  14. Lifesciences
  15. In Vitro
  16. GLP
  17. Biochemistry
  18. Venture Capital
  19. CRO
  20. Clinical Trials
  21. Pharmacology
  22. Biopharmaceuticals
  23. Clinical Research
  24. Commercialization
  25. Immunology
  26. Technology Transfer
  27. Biomarkers
  28. Oncology
  29. Pharmaceutical Industry

View All (29) Skills View Fewer Skills

Nathalie Compagnone's Education

HEC School of Management

Executive program, Growth Strategy, Entrepreneurship & decision making, Marketing of innovation, Finances

20102011

Activities and Societies: • Créativité – Innovation - Stratégie • International : définir et mettre en œuvre sa stratégie de développement • La stratégie financière au service du développement de l’entreprise • Développement commercial : stratégie,relation client et organisation interne

Rutgers, The State University of New Jersey-New Brunswick

Mini MBA, Global Biopharma Entrepreneurship

20102010

Activities and Societies: Mini-MBA entrepreneurship in health care industries

University of California San Francisco

CBE, Management & Financing

20042004

Université de Besançon - Franche-comté

PhD, Embryology, Histology, Neuroendocrinology

19891993

Hypothalamic neurons expressing the melano-concentrating hormmone
- Culture system
- Pharmacology

Activities and Societies: CNRS URA561

Université de Besançon - Franche-comté

DEA, Biochemistry, cellular and molecular biology

19871988

INSERM U198- Hormonal communications

Ecole Supérieure d'Agriculture d'Angers

Engineer, Agriculture, Food processing & Biotechnology

19821986

Nathalie Compagnone's Additional Information

Websites:
Interests:

drug safety, pre-clinical safety, mitochondrial liabilities, clinical tolerance, system biology, in vitro testings, CRO, biomarker, neurodegeneration, ageing, muscular dystrophy, confidence in safety, confidence in efficacy

Groups and Associations:
Honors and Awards:

2011- ICDD making national news with a presentation of France3 : http://www.icdd-sas.com/icdd-on-the-news-2/
2010- Successful benchmarking of the mitostream® technology through a CTE consortium with the DSEC, counting 8 big and mid-size pharma.
2009- Selected best innovative services by professionals.
2009- Laureat CCETI of the ministry of research and OSEO, category "creation-development"
Various awards and prize from OSEO, CCI-MP, DAP, FIBM, have honnored ICDD's innovative concepts.

Contact Nathalie for:

  • job inquiries
  • expertise requests
  • business deals
  • reference requests
  • getting back in touch

View Nathalie Compagnone’s full profile to...

  • See who you and Nathalie Compagnone know in common
  • Get introduced to Nathalie Compagnone
  • Contact Nathalie Compagnone directly

View Nathalie's full profile

Viewers of this profile also viewed...